Funds and ETFs CALYXTPAR

Equities

CLXT

US13173L2060

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq 06:00:00 2024-02-04 pm EST 5-day change 1st Jan Change
17.59 USD -.--% Intraday chart for CALYXTPAR +2.93% -10.44%

ETFs positioned on CALYXTPAR

Name Weight AuM 1st Jan change Investor Rating
0.40% 4 M€ -5.15% -
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
15.84 USD
Average target price
23 USD
Spread / Average Target
+45.20%
Consensus
  1. Stock Market
  2. Equities
  3. CLXT Stock
  4. Funds and ETFs CALYXTPAR